OA09.06 Vascular Leakage Promotes Immunosuppression and is Associated with Reduced Patient Survival in Non-Small Cell Lung Cancer

      Vascular hyperpermeability (leakage) facilitates tumor progression, metastasis, and limited delivery of therapeutics by fostering a hypoxic tumor microenvironment. Recently, pharmacological inhibition of vascular leakage enhanced tumor infiltration and activity of cytotoxic (CD8+) T-cells when used in combination with anti-PD1 blockade. However, the influence of vascular leakage on the tumor immune contexture and prognostic implications in human cancer patients remains to be investigated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Thoracic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect